1696PA randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B-cell non-Hodgkin lymphomas (B-NHL): AVOID neutropenia. (23rd October 2018) - Link, H; Illerhaus, G; Martens, U M; Salar, A; Depenbusch, R; Kohler, A; Engelhardt, M M; Mahlmann, S; Zaiss, M; Lammerich, A; Bias, P; Buchner, A